Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123296) titled '20220225 Mechanistic Study of Molecular Diagnostic Technology Based on the CRISPRCas System' on April 23.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Hepatitis B virus
coronavirus
Mycobacterium tuberculosis
Intervention:
Gold Standard:RT-PCR
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-23
Target Sample Size: Target condition:60;Difficult condition:60
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318714
Disclaimer: Curated b...